Kismet Technologies sells to businesses rather than direct to researchers. It also produces and labels to order, so stock sold under other brand names may come from here.
In its own words: “Our mission is to create groundbreaking material technologies that mitigate harmful microbes, enhancing the quality of life for people everywhere. We envision a world where our innovative solutions lead the way in fostering healthier, safer environments across the globe, all while minimizing our impact on the planet.”
Kismet Technologies publishes 2 certificates of analysis on its site. The vendor chose which batches to publish, so those results do not tell you what is in the vial you receive.
Site check: 2 certificates of analysis published.
Kismet Technologies is listed as active. Tracked by Finnrick. No test data available yet.
| Status | Active |
|---|---|
| Vendor type | Research-use supplier |
These details were read from Kismet Technologies's own website on 2026-08-17. Pages consulted:
Kismet Technologies is listed as active and we hold 2 certificates of analysis published on its own site. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
We hold no independent third-party assays for Kismet Technologies. Any purity figure it publishes is self-reported unless it names the lab that produced it.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Kits4less Peptides Review, Kitsune Compounds Peptides Review, Konors Peptide Review.